Homepage

2019/05/09MEDICAL UPDATE

Advances in RRMM

Interviewer: Hannah Chatfield, Article: Maria Dalby

READ MORE

2019/05/08MEDICAL UPDATE

Transplantation, Consolidation and Maintenance

Interviewer: Hannah Chatfield, Article: Maria Dalby Autologous stem cell transplantation (ASCT) remains the standard of care option for those patients with newly-diagnosed multiple myeloma (MM) who are eligible for and able to tolerate it. However, consolidation and/or maintenance therapies are required to ensure maximum benefit of the initial therapy and to maintain disease control for as long as possible.

READ MORE

2019/05/07MEDICAL UPDATE

Integrating CAR T-Cell therapy into the treatment of myeloma

Interviewer: Hannah Chatfield, Article: Maria Dalby

READ MORE

2019/05/06MEDICAL UPDATE

State of the art clinical trials

Interviewer: Hannah Chatfield, Article: Maria Dalby

READ MORE

2019/05/05MEDICAL UPDATE

Bridging the gap between clinical trial results and real-world myeloma practices

Interviewer: Hannah Chatfield, Article: Maria Dalby

READ MORE

2019/05/04MEDICAL UPDATE

Maintenance therapy in newly diagnosed MM – a reality in the UK?

READ MORE

2019/05/03MEDICAL UPDATE

What are the opportunities for genomic-driven change in lymphoma?

Interviewer: Hannah Chatfield, Article: Maria Dalby

READ MORE

2019/05/02MEDICAL UPDATE

Frontline therapy in multiple myeloma therapy: current evidence and future research

Interviewer: Hannah Chatfield, Article: Maria Dalby

READ MORE

2019/05/01MEDICAL UPDATE

Highlights from BSH 2019

Interviewer: Hannah Chatfield, Article: Maria Dalby

READ MORE

2019/05/01MEDICAL UPDATE

EHA 2018: UK Real-world outcomes in NDMM

Interview by Esther Drain, Article by Maria Dalby)

READ MORE